溃疡性结肠炎及其与巨细胞病毒的相关性
Ulcerative Colitis and Its Association with Cytomegalovirus
DOI: 10.12677/ACM.2022.126796, PDF,   
作者: 李梦鸽, 赵 雪, 方世淼：西安医学院，陕西 西安；刘贵生*, 吕颐菲：陕西省人民医院消化内科，陕西 西安
关键词: 溃疡性结肠炎；巨细胞病毒；抗病毒治疗；Ulcerative Colitis； Cytomegalovirus； Antiviral Therapy
摘要: 近年来，溃疡性结肠炎的发病率呈上升态势。在本病的治疗中，应用激素或免疫抑制剂是不可避免的，疾病后续所带来的感染主要是由巨细胞病毒引起的。随着对疾病的逐渐了解，有必要尽快对其开始治疗干预，以避免疾病恶化或发展为难治性溃疡。本文综述了两者之间的相关性，并阐述了本病的治疗和预后。
Abstract: In recent years, the incidence of ulcerative colitis has increased. The use of hormones or immuno-suppressants is unavoidable in the treatment of this disease, and the subsequent infection of the disease is mainly caused by cytomegalovirus. With the gradual understanding of the disease, it is necessary to start therapeutic interventions on it as soon as possible to avoid worsening of the dis-ease or the development of refractory ulcers. This article reviews the correlation between the two and describes the treatment and prognosis of the disease.
文章引用：李梦鸽, 赵雪, 方世淼, 刘贵生, 吕颐菲. 溃疡性结肠炎及其与巨细胞病毒的相关性[J]. 临床医学进展, 2022, 12(6): 5506-5511. https://doi.org/10.12677/ACM.2022.126796

参考文献

[1] Jentzer, A. (2020) Cytomegalovirus and Inflammatory Bowel Diseases (IBD) with a Special Focus on the Link with Ul-cerative Colitis (UC). Microorganisms, 8, 1078. [Google Scholar] [CrossRef] [PubMed]
[2] Mourad, F.H. (2020) Ulcerative Colitis and Cytomegalovirus Infection: From A to Z. Journal of Crohn’s and Colitis, 14, 1162-1171. [Google Scholar] [CrossRef] [PubMed]
[3] 温航卫, 肖吉平, 肖成平, 刘辉, 夏欢. 布拉氏酵母菌联合更昔洛韦治疗巨细胞病毒感染相关性溃疡性结肠炎[J]. 实用儿科临床杂志, 2012, 27(19): 1525-1526.
[4] 魏民华, 尹凤荣, 杨少鹏, 雷蕾, 郭金波, 王冬, 张晓岚. 溃疡性结肠炎患者巨细胞病毒感染或再激活危险因素的Meta分析[J]. 中华实验和临床病毒学杂志, 2019(5): 541-546.
[5] 陈白莉, 钟碧慧, 张芳宾, 胡品津. 重度溃疡性结肠炎合并巨细胞病毒肠炎一例[J]. 中华内科杂志, 2010(5): 437-438.
[6] 孙渊, 杨红. 初发型溃疡性结肠炎合并机会感染1例报道[J]. 胃肠病学和肝病学杂志, 2016(3): 359-360.
[7] Römkens, T.E. (2016) Cytomegalo-virus in Inflammatory Bowel Disease: A 1. Systematic Review. World Journal of Gastroenterology, 22, 1321-1330. [Google Scholar] [CrossRef] [PubMed]
[8] Levin, A. (2017) Diagnosis of Cytomegalovirus Infection during Ex-acerbation of Ulcerative Colitis. Digestion, 96, 142-148. [Google Scholar] [CrossRef] [PubMed]
[9] 黎涛, 赵平. 溃疡性结肠炎患者感染巨细胞病毒的临床特征及相关危险因素分析[J]. 解放军预防医学杂志, 2019(1): 28-31.
[10] 张瑜鸿, 苗新普. 溃疡性结肠炎并发巨细胞病毒感染的临床特征及危险因素[J]. 实用预防医学, 2018, 25(3): 338-341.
[11] 徐刚, 余林蔓, 何兴元. 溃疡性结肠炎感染巨细胞病毒的危险因素、临床特征、临床结局分析[J]. 胃肠病学和肝病学杂志, 2016, 25(10): 1144-1147.
[12] 费秀昆. 溃疡性结肠炎合并巨细胞病毒感染的临床特点分析[J]. 中国农村卫生, 2017(14): 14-15.
[13] 李骥, 韦明明, 谭蓓, 李玥, 杨红, 吕红, 王丽瑛, 李景南, 朱峰, 钱家鸣. 活动性巨细胞病毒感染和糖皮质激素抵抗是溃疡性结肠炎患者手术的独立危险因素[J]. 中华内科杂志, 2015(11): 936-939.
[14] Nakase, H. (2014) Diagnosis and Treatment of Ulcerative Colitis with Cytomegalovirus Infec-tion: Importance of Controlling Mucosal Inflammation to Prevent Cytomegalovirus Reactivation. Intestinal Research, 12, 5-11. [Google Scholar] [CrossRef] [PubMed]
[15] 薛猛, 姒健敏. 巨细胞病毒: 激素难治性溃疡性结肠炎的一个可能病因[J]. 胃肠病学, 2013, 18(10): 580-585.
[16] 陈健, 甘少光, 陈铸雄, 严衍伟, 欧建爱. 巨细胞病毒感染和难治性溃疡性结肠炎的关系分析[J]. 现代诊断与治疗, 2016, 27(13): 2495-2496.
[17] 林冠霞, 黄伟峰, 史美娜, 徐桂华. 溃疡性结肠炎合并巨细胞病毒感染患者临床特点[J]. 中华实验和临床病毒学杂志, 2018, 32(3): 305-308.
[18] 黄英, 杨雪松, 李军, 陈晨. 溃疡性结肠炎合并巨细胞病毒感染的临床特点及转归[J]. 临床消化病杂志, 2020, 32(1): 25-30.
[19] 焉鹏, 陈双峰, 梁爱军, 马宁. 人巨细胞病毒感染与溃疡性结肠炎关系的研究[J]. 山东医药, 2005, 45(22): 36-37.
[20] 李甜甜, 吕宗舜, 王邦茂, 张洁. 难治性溃疡性结肠炎与巨细胞病毒的关系[J]. 世界华人消化杂志, 2010, 18(11): 1174-1177.
[21] 申洋, 胡仁伟. 重度溃疡性结肠炎患者感染巨细胞病毒的危险因素分析及抗病毒治疗[J]. 热带医学杂志, 2020, 20(6): 791-794+798.
[22] 刘萱, 于中麟, 张澍田. 诊治溃疡性结肠炎应警惕人巨细胞病毒感染[J]. 中华内科杂志, 2010, 49(8): 648.
[23] 刘京龙, 席静静. 巨细胞病毒感染的难治性溃疡性结肠炎优化治疗方案[J]. 中国药物与临床, 2019, 19(3): 477-479.
[24] 贾国葆, 吴建胜, 吴亮, 黄智铭, 陈向荣. 巨细胞病毒在炎症性肠病中的临床意义及其诊治策略[J]. 医学研究杂志, 2017, 46(3): 102-105.
[25] 张淑芳, 杨涛, 姚萍. 溃疡性结肠炎合并巨细胞病毒感染的相关研究进展[J]. 世界最新医学信息文摘, 2019, 19(12): 89-90.
[26] Park, S.C. and Jeen, Y.M. (2017) Approach to Cytomegalovirus Infections in Patients with Ulcerative Coli-tis. The Korean Journal of Internal Medicine, 32, 383-392. [Google Scholar] [CrossRef] [PubMed]
[27] 王晓喆, 杨红, 庞钧译, 周炜洵. 巨细胞病毒在左半及右半结肠中感染检出量差异分析[J]. 中华病理学杂志, 2020, 49(6): 583-587.
[28] 杨红, 钱家鸣. 溃疡性结肠炎合并巨细胞病毒感染中病毒血症及内镜特点与组织病理相关性[J]. 中华内科杂志, 2017, 56(8): 617-617.
[29] Zidar, N. (2016) Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology? The American Journal of Gastroenterology, 111, 1658. [Google Scholar] [CrossRef] [PubMed]
[30] Li, D., Yang, Y., Yin, X., et al. (2021) Glucagon-Like Peptide (GLP)-2 Improved Colonizing Bacteria and Reduced Severity of Ulcerative Colitis by Enhancing the Diversity and Abundance of Intestinal Mucosa. Bioengineered, 12, 5195-5209. [Google Scholar] [CrossRef] [PubMed]
[31] 赵可, 李弼民, 邸雅南, 谢正兴, 李丽坤, 张波, 彭德银. 巨细胞病毒感染与炎症性肠病相关性研究[J]. 中国医药导刊, 2011, 13(11): 1863-1865.
[32] Pillet, S. (2016) Cytomegalovirus and Ulcerative Colitis: Place of Antiviral Therapy. World Journal of Gastroenterology, 22, 2030-2045. [Google Scholar] [CrossRef] [PubMed]
[33] Tamura, S., Osawa, S., Ishida, N., et al. (2021) Prevalence of UL97 Gene Mutations and Polymorphisms in Cytomegalovirus Infec-tion in the Colon Associated with or without Ulcerative Colitis. Scientific Reports, 11, Article No. 13676. [Google Scholar] [CrossRef] [PubMed]
[34] 吴斌, 钟敏儿. 《溃疡性结肠炎外科治疗欧洲循证共识》解读[J]. 胃肠病学, 2016, 21(12): 705-707. [Google Scholar] [CrossRef] 
[35] Wada, Y. (2003) Intractable Ulcerative Colitis Caused by Cytomegalovirus Infection: A Prospective Study on Prevalence, Diagnosis, and Treatment. Diseases of the Colon & Rectum, 46, S59-S65.
[36] 黄丽, 唐清. 炎症性肠病合并巨细胞病毒感染的研究进展[J]. 广西医科大学学报, 2020, 37(2): 320-325.
[37] Watanabe, Y., Hayashi, K. and Terai, S. (2021) A Rare Case of Ulcerative Colitis with Se-vere Pneumocystis jirovecii Pneumonia and Cytomegalovirus Colitis: A Case Report and Literature Review. Internal Medicine, 61, 339-344.
[38] Ciccocioppo, R., Mengoli, C., Betti, E., et al. (2021) Human Cytomegalovirus and Ep-stein-Barr Virus Specific Immunity in Patients with Ulcerative Colitis. Clinical and Experimental Medicine, 21, 379-388. [Google Scholar] [CrossRef] [PubMed]
[39] 尹凤荣, 魏民华, 雷蕾, 郭金波, 霍晓霞, 张晓岚. 巨细胞病毒感染和抗病毒治疗对溃疡性结肠炎患者预后影响的meta分析[J]. 胃肠病学, 2018, 23(4): 231-237.

为你推荐